When Payment Systems Collide The Effect of Hospitalization on Anemia in Renal Dialysis Patients

被引:5
|
作者
Turenne, Marc N. [1 ,2 ]
Hirth, Richard A. [2 ]
Messana, Joseph M. [3 ]
Turner, Jason S. [5 ]
Sleeman, Kathryn K. [4 ]
Wheeler, John R. C. [2 ]
机构
[1] Univ Michigan, Kidney Epidemiol & Cost Ctr, Sch Publ Hlth, Ann Arbor, MI 48103 USA
[2] Univ Michigan, Dept Hlth Management & Policy, Ann Arbor, MI 48103 USA
[3] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48103 USA
[4] Univ Michigan, Dept Biostat, Ann Arbor, MI 48103 USA
[5] St Louis Univ, Dept Hlth Management & Policy, St Louis, MO 63103 USA
关键词
payment system; financial incentives; unintended consequences; renal failure; anemia management; hospitalization; Medicare; ACUTE MYOCARDIAL-INFARCTION; QUALITY; CARE; TIME; DISPARITIES;
D O I
10.1097/MLR.0b013e3181c161ce
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Different types of providers often face differing financial incentives for providing similar types of care. This may have implications for payment systems that target improvements in care requiring multiple types of providers. Objectives: The objective of this study was to determine how hospitalization influences the anemia of Medicare patients with chronic renal failure, where anemia is treated under a prospective payment system during hospitalizations and under a fee-for-service system during outpatient renal dialysis. Methods: We examined the effects of time in hospital and reason for hospitalization on levels of anemia among 87,263 Medicare renal dialysis patients with a hospital stay of 3 days or more during 2004. Medicare claims were used to measure changes in hematocrit between the month before and the month after hospital discharge, and to classify admissions with a high risk of anemia. Multilevel models were used to study variation in outcomes across providers. Results: Longer time in the hospital was associated with worsening anemia. As expected, larger declines in hematocrit occurred following admissions for conditions or procedures with a high risk of anemia. However, we observed a similar effect of time in the hospital for admissions both with and without a high risk of anemia. There were relatively large differences in anemia outcomes across both individual hospitals and physicians. Conclusions: Hospitalization-related anemia increases the need for care by outpatient renal dialysis providers. Efforts to improve care through payment system design are more likely to be successful if financial incentives are aligned across care settings.
引用
收藏
页码:296 / 305
页数:10
相关论文
共 50 条
  • [21] TRENDS IN ANEMIA MANAGEMENT FOR END STAGE RENAL DISEASE (ESRD) PATIENTS ON DIALYSIS
    Wish, Jay
    Hariri, Ali
    Harrison, Will
    Yang, Alex
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2012, 59 (04) : A90 - A90
  • [22] Roxadustat for anemia in patients with end-stage renal disease incident to dialysis
    Provenzano, Robert
    Shutov, Evgeny
    Eremeeva, Liubov
    Korneyeva, Svitlana
    Poole, Lona
    Saha, Gopal
    Bradley, Charles
    Eyassu, Meraf
    Besarab, Anatole
    Leong, Robert
    Liu, Cameron S.
    Neff, Thomas B.
    Szczech, Lynda
    Yu, Kin-Hung P.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36 (09) : 1717 - 1730
  • [23] ENDURANCE CAPACITY OF DIALYSIS PATIENTS WITH RENAL ANEMIA UNDER ERYTHROPOIETIN (EPO) ADMINISTRATION
    JEDICKE, H
    LANGE, H
    KIDNEY INTERNATIONAL, 1991, 39 (06) : 1305 - 1305
  • [24] Effect of End-Stage Renal Disease Prospective Payment System on Utilization of Peritoneal Dialysis in Patients with Kidney Allograft Failure
    Gardezi, Ali I.
    Yuan, Zhongyu
    Aziz, Fahad
    Parajuli, Sandesh
    Mandelbrot, Didier
    Chan, Micah R.
    Astor, Brad C.
    AMERICAN JOURNAL OF NEPHROLOGY, 2024, 55 (05) : 551 - 560
  • [25] EFFECT OF RENAL DIALYSIS ON CHRONIC-SCHIZOPHRENIC PATIENTS
    WAGEMAKER, H
    CADE, R
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1977, 21 (01) : 121 - 122
  • [26] Effect of Roxadustat on Thyroid Function in Patients With Renal Anemia
    Haraguchi, Takuya
    Hamamoto, Yoshiyuki
    Kuwata, Hitoshi
    Yamazaki, Yuji
    Nakatani, Susumu
    Hyo, Takanori
    Yamada, Yuichiro
    Yabe, Daisuke
    Seino, Yutaka
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 109 (01): : e69 - e75
  • [27] Effect of Roxadustat on Thyroid Function in Patients With Renal Anemia
    Haraguchi, Takuya
    Hamamoto, Yoshiyuki
    Kuwata, Hitoshi
    Yamazaki, Yuji
    Nakatani, Susumu
    Hyo, Takanori
    Yamada, Yuichiro
    Yabe, Daisuke
    Seino, Yutaka
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 109 (01): : e69 - e75
  • [28] EFFECT OF CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS ON ANEMIA IN UREMIC PATIENTS
    MARCOVICI, O
    BONER, G
    ROSENFELD, JB
    ISRAEL JOURNAL OF MEDICAL SCIENCES, 1983, 19 (07): : 604 - 607
  • [29] The prospective effect of psychosocial factors on peritonitis and hospitalization rates in peritoneal dialysis patients
    Bilgic, Ayse
    Alsancak, Ruya
    Sezer, Siren
    Koc, Serkan Kubilay
    Ibis, Avsin
    Ozdemir, Fatma Nurhan
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 309 - 309
  • [30] Switching epoetin alfa and epoetin zeta in patients with Renal Anemia on Dialysis: Posthoc analysis
    Andrzej Więcek
    Islah Ahmed
    Paul Scigalla
    Rossen Koytchev
    Advances in Therapy, 2010, 27 : 941 - 952